George Oliveira, MD
Vascular & Interventional Radiology · Miami, FLNPI 1285895318
Payments from drug & device makers
Across 764 payments — averaging $4076.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$626K
- Astrazeneca UK Limited$580K
- Merck$479K
- Roche Products Limited$308K
- E.r. Squibb & Sons, L.L.C.$239K
- Hoffmann-la Roche Limited$187K
- plus $696K from 24 others
Across 33 payments — averaging $6105.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$106K
- Eli Lilly$75K
- Regeneron$18K
- Epizyme, Inc.$3K
- Ipsen Innovation$75
What the payments were for
- Consulting fees$665,780100%
- Food & beverage$2740%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 52 | $625,667 |
| Astrazeneca UK Limited | 33 | $579,523 |
| Merck | 252 | $478,925 |
| Roche Products Limited | 69 | $308,355 |
| E.r. Squibb & Sons, L.L.C. | 17 | $239,415 |
| Hoffmann-la Roche Limited | 10 | $186,845 |
| Pfizer | 130 | $185,355 |
| Acerta Pharma LLC | 10 | $107,577 |
| Takeda Pharmaceuticals U.S.A., Inc. | 26 | $86,240 |
| Dr.reddy's Laboratories,inc. | 36 | $57,660 |
| Beigene, Ltd. | 22 | $47,640 |
| Pharmacyclics LLC, An Abbvie Company | 17 | $34,735 |
| Astellas Pharma Global Development | 4 | $34,580 |
| Genentech, Inc. | 21 | $25,846 |
| Beone Medicines Ltd. | 11 | $24,540 |
| Amgen | 3 | $21,825 |
| Novartis | 3 | $21,250 |
| Beigene (suzhou) Co., Ltd. | 6 | $13,825 |
| EMD Serono, Inc. | 5 | $9,640 |
| Verastem, Inc. | 7 | $7,150 |
| Bristol Myers Squibb | 1 | $6,090 |
| Secura Bio, Inc. | 6 | $4,290 |
| Janssen Research & Development, LLC | 5 | $1,940 |
| AbbVie | 1 | $1,600 |
| Beigene AUS Pty Ltd | 2 | $1,200 |
| Novartis Pharma AG | 5 | $1,175 |
| Eisai Inc. | 1 | $750 |
| Sanofi US Services Inc. | 4 | $750 |
| Penumbra, Inc. | 2 | $173 |
| Cook Medical LLC | 3 | $101 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,114,663 in reported general payments places this provider in the 95th percentile of 329 vascular & interventional radiology providers in Florida.
See all vascular & interventional radiology providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other vascular & interventional radiology in Miami
- Ripal GandhiMiami$2.9M
- Robert BeasleyMiami$979K
- Govindarajan NarayananMiami$442K
- Brian SchiroMiami$295K
- Keith PereiraMiami$271K
- Paul RotoloMiami$171K
- James BenenatiMiami$126K
- Bedros TaslakianMiami$53K
- Douglas ColdwellMiami$49K
- Lindsay ThorntonMiami$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.